Literature DB >> 17167113

Association between serum lipids and survival in hemodialysis patients and impact of race.

Ryan D Kilpatrick1, Charles J McAllister, Csaba P Kovesdy, Stephen F Derose, Joel D Kopple, Kamyar Kalantar-Zadeh.   

Abstract

Despite the enormous cardiovascular disease epidemic among maintenance hemodialysis (MHD) patients, total hypercholesterolemia seems paradoxically to be associated with better survival. It was hypothesized that similar paradoxic associations also exist for serum LDL, HDL, and triglycerides. A 3-yr (July 2001 through June 2004) cohort of 15,859 MHD patients was studied in the United States from DaVita dialysis clinics where lipid profile was measured in at least 50% of all outpatients during a given calendar quarter. Cox proportional hazard models were adjusted for case mix and surrogates of malnutrition-inflammation complex. Both total and LDL hypercholesterolemia showed a paradoxic association with better survival. Hypertriglyceridemia (>200 mg/dl) also showed a similar trend, but serum HDL cholesterol did not have any clear association with survival. The association between a low serum LDL <70 mg/dl, which was prevalent among almost 50% of all MHD patients, and a higher all-cause death risk was robust to multivariate adjustment. In the subgroup analyses, these paradoxic associations persisted among most subgroups, although they tended to be stronger among hypoalbuminemic (<3.8 mg/dl) patients and those with a lower dietary protein intake (<1 g/kg per d). However, in black patients, a high serum LDL (>100 mg/ml) was associated with adjusted cardiovascular death hazard ratio of 1.94 (95% confidence interval 1.12 to 2.38; P = 0.02). Despite inverse associations between hyperlipidemia and survival, black MHD patients with high LDL show almost two-fold increase in cardiovascular death risk. Although these associations may not be causal, they call into question whether specific subgroups of dialysis patients are better targets for cholesterol-lowering therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17167113     DOI: 10.1681/ASN.2006070795

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  82 in total

1.  Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus.

Authors:  Uyen Duong; Rajnish Mehrotra; Miklos Z Molnar; Nazanin Noori; Csaba P Kovesdy; Allen R Nissenson; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Serum amyloid A in uremic HDL promotes inflammation.

Authors:  Thomas Weichhart; Chantal Kopecky; Markus Kubicek; Michael Haidinger; Dominik Döller; Karl Katholnig; Cacang Suarna; Philipp Eller; Markus Tölle; Christopher Gerner; Gerhard J Zlabinger; Markus van der Giet; Walter H Hörl; Roland Stocker; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

Review 3.  Lipid abnormalities in kidney disease and management strategies.

Authors:  Vishwam Pandya; Akhilesh Rao; Kunal Chaudhary
Journal:  World J Nephrol       Date:  2015-02-06

Review 4.  Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.

Authors:  Nosratola D Vaziri
Journal:  Clin Exp Nephrol       Date:  2013-08-24       Impact factor: 2.801

5.  Apoprotein B/Apoprotein A-1 Ratio and Mortality among Prevalent Dialysis Patients.

Authors:  Yuji Sato; Shouichi Fujimoto; Tatsunori Toida; Hideto Nakagawa; Yasuhiro Yamashita; Takashi Iwakiri; Akihiro Fukuda; Shuji Iwatsubo
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-15       Impact factor: 8.237

6.  Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Deborah L Regidor; Csaba P Kovesdy; David Van Wyck; Suphamai Bunnapradist; Tamara B Horwich; Gregg C Fonarow
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

7.  Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients.

Authors:  Ronney Shantouf; Matthew J Budoff; Naser Ahmadi; Jima Tiano; Ferdinand Flores; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2007-11-09       Impact factor: 3.754

8.  Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study.

Authors:  Mehdi Rambod; Rachelle Bross; Jennifer Zitterkoph; Deborah Benner; Juhi Pithia; Sara Colman; Csaba P Kovesdy; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2008-12-13       Impact factor: 8.860

9.  Disorders of lipid metabolism and chronic kidney disease in the elderly.

Authors:  Devasmita Choudhury; Meryem Tuncel; Moshe Levi
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

10.  Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients.

Authors:  Deborah L Regidor; Csaba P Kovesdy; Rajnish Mehrotra; Mehdi Rambod; Jennie Jing; Charles J McAllister; David Van Wyck; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.